Ipatimup

RESEARCHDIAGNOSTICSTRANSLATIONOUTREACH

Marta Pinto

Name: Marta Pinto

E-mail: mtpinto@i3s.up.pt

Extension:

225570700

Marta Pinto

Member of

Lab Manager of In vivo CAM Assays

Short CV

Marta Teixeira Pinto (MT Pinto) is responsible for the i3S Scientific Platform in vivo CAM assays provides custom-made in vivo assays using the chick embryo chorioallantoic membrane (CAM) model.

MT Pinto graduated in Biochemistry (FCUP, 1999), completed her MSc degree in Neurosciences (FMUL, 2001) and obtained her PhD in Human Biology (FMUP, 2008). MT Pinto joined Ipatimup as an Investigator (Ciência2008) of the Cancer Genetics Group and was mainly dedicated to study cancer angiogenesis, invasion and metastasis, using an animal model that fulfills the 3Rs principals. After setting up the laboratory and implementing several important assays, MT Pinto established the platform in 2012.

MT Pinto also developed skills and training in entrepreneurship, innovation , IP protection, science communication, science policy and science management throughout her scientific career.

MT Pinto is author in 44 publications in several topics, having more than 1250 citations and h-Index of 21.

Highlights

Marta Teixeira Pinto specific focus of research is to evaluate angiogenesis, invasion and metastization using multidisciplinary approaches that include both in vitro and in vivo chick embryo assays.

First Author

1. Pinto MT, Ribeiro AS, Conde I, Carvalho R, Paredes J

The Chick Chorioallantoic Membrane Model: A New In Vivo Tool to Evaluate Breast Cancer Stem Cell Activity. International journal of molecular sciences 22: ., 2020. [Article]

doi: 10.3390/ijms22010334 PMID: 33396951.

5.9

2. Pinto M, Soares P, Ribatti D

Thyroid hormone as a regulator of tumor induced angiogenesis. Cancer letters 301: 119-26, 2011. [Review]

doi: 10.1016/j.canlet.2010.11.011 PMID: 21183275.

4.2

@ 2014 Ipatimup Institute of Molecular Pathology and Immunology of the University of Porto